The ‘AI119 Project’ is currently assisting disabled Harvard students in civil rights actions and military veterans at ...

NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend ...

FORT WORTH, Texas, Dec. 24, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced the effectiveness of a three-for-one forward stock split, along with a proportionate increase in ...

Said Mr. Rajiv Shukla, Chairman of Carmell, “We are happy to announce an additional round of investment from existing and new investors to support the continued commercial build out of our ...

In addition, further additional liquidity in the amount of approximately $5.5 million has been provided to Trinity Biotech through a combination of cash and payment-in-kind interest, strengthening ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Des résultats de l’étude sur la polyarthrite rhumatoïde récemment conduite soulèvent des questions ...

Registered nurses from across the world can submit their applications through www.asterguardians.com in their preferred languages by February 10, 2025.

“We are pleased that as a leader in Oncology, AstraZeneca recognizes the scientific value of our TRACERx and MAP assets,” said Dr Iraj Ali, CEO of Achilles Therapeutics. “We believe that these assets ...

The CEO Corner segment is now available here. About Autonomix Medical, Inc.

CORXEL expands its cardiometabolic pipeline into obesity and diabetes. NEW JERSEY and SHANGHAI, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Corxel Pharmaceuticals (CORXEL), a leading biotec ...

The gross proceeds to the Company from the offering are expected to be approximately $3.5 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The ...